Bayer   Report issue

Contributed to NME For profit Phase 1 Phase 2 Phase 3 Phase 4
Founded: Barmen Germany (1863)

Organization Overview

First Clinical Trial
1993
NCT00311870
First Marketed Drug
1949
cyanocobalamin (berocca)
First NDA Approval
1965
acetylsalicylic acid (aspirin)
Last Known Activity
2021

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Bayer | BAYER | Bayer AG (Sponsor) | Bayer (collaborator) | BAYER HEALTHCARE | BAYER HEALTHCARE LLC | Bayer Healthcare Pharmaceuticals, Inc./Bayer Schering Pharma | BAYER HEALTHCARE PHARMS | BAYER HLTHCARE | Bayer/Onyx | BAYER PHARMS | BAYER S.p.A. - Italia | Bayer University Kano, Nigeria | Bayer (v1) | Bayer (v2) | Bayer Yakuhin, Ltd. | University of Goettingen, Section Neurobiology (Head: Prof. Dr. T. Bayer), Germany